Primary Record
sotuletinib
- In stock
- 3,883 g
- Purity
- 98.4 %
- CAS
- 953769-46-5
Compound Identifiers & Properties
- CAS
- 953769-46-5
- PubChem CID
- 46184986
- SMILES
- CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)N[C@@H]4CCCC[C@H]4O
- Canonical SMILES
- CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1
Names & Synonyms
- sotuletinib
- BLZ945
- BLZ-945
- 953769-46-5
- UNII-7W3V82OQ0P
- 7W3V82OQ0P
- BLZ 945
- RefChem:120669
- SOTULETINIB [INN]
- MFCD28142668
- D08NDE
- MIDODRINEHYDROCHLORIDE
- CHEMBL4227505
- C20H22N4O3S
- CSF-1R INHIBITOR BLZ945
- GTPL8250
- orb1301056
- P-BLZ945
- SCHEMBL2676695
- BLZ 945 [WHO-DD]
- SCHEMBL29368442
- SCHEMBL29368661
- 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide
- CSF-1R inhibitor (bone cancer)
- EX-A817
- SYN1197
- ADZBMFGQQWPHMJ-RHSMWYFYSA-N
- GLXC-90408
- KS-00001D1X
- 3193AH
- BDBM50460035
- HB4634
- NSC758006
- s7725
- ZINC68203100
- AKOS025396391
- CCG-268639
- CS-3971
- EBC-220043
- NSC-758006
- NCGC00386432-02
- NCGC00386432-03
- NCGC00386432-07
- AC-32994
- AS-16330
- BB178452
- BC600698
- CID:46184986
- DA-61754
- HY-12768
- QC-11680
- SY047892
- CSF-1R inhibitor (bone cancer), Novartis
- SID:144221040
- 4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-2-pyridinecarboxamide
- B4899
- J3.661.938D
- A15540
- I10001
- 2-Pyridinecarboxamide, 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)-6-benzothiazolyl)oxy)-N-methyl-
- A900149
- C568289
- Q27075332
- 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide
- 4-((2-(((1R,2R)-2-Hydroxycyclohexyl)amino)benzo-[d]thiazol-6-yl)oxy)-N-methylpicolinamide
- B0084-463485
- 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzo[d]thiazol-6-yloxy)-N-methylpicolinamide
- 4-[(2-{[(1R,2R)-2-HYDROXYCYCLOHEXYL]AMINO}-1,3-BENZOTHIAZOL-6-YL)OXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE
- 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo(d)thiazol-6-yl)oxy)-N-methylpicolinamide
- 4-(2-(2-hydroxycyclohexylamino)benzothiazol-6-yloxy)pyridine-2-carboxylic acid methylamide
- 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)-1,3-benzothiazol-6-yl)oxy)-N-methylpyridine-2-carboxamide
- 4-(2((1R,2R)-2-Hydroxycyclohexylamino)-benzothiazol-6-yloxyl)-pyridine-2-carboxylic Acid Methylamide
- 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methyl-pyridine-2-carboxamide
- 4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methylpyridine-2-carboxamide
- N-Methyl-4-[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]benzothiazole-6-yloxy]pyridine-2-carboxamide